Fundraising FoxClinigence Holdings
NASDAQ: NUTXAtlanta, US · Founded 2018 · Delaware corporation
Find your way into Clinigence Holdings
Sign up to see every warm intro you have to Clinigence Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Clinigence Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nutex Health is a publicly traded healthcare management and operations company that owns, develops, and operates micro-hospitals, specialty hospitals, and hospital outpatient departments, as well as physician provider networks such as IPAs and MSOs. It serves communities and physician groups across the United States, operating over 27 facilities in 12 states with a focus on emergency and concierge-level care.
Founders & leadership
Clinigence Holdings was founded in 2018 by Jacob Margolin.
JM
Jacob MargolinChief Executive Officer, President and Secretary
MS
Mihir ShahChief Financial Officer
EL
Elisa LuqmanExecutive
DM
David MeiriNamed on SEC filing
MC
Mitchell CreemNamed on SEC filing
MF
Mark FawcettNamed on SEC filing
JW
John WatersNamed on SEC filing
Board
MB
Martin BreslinBoard director
LS
Lawrence SchimmelBoard director
WH
Warren HosseinionBoard director
Reported raises · per SEC filings
Form D private placements$2.5B disclosed across 8 rounds · 2018–2023
▶$3.1MraisedOct 2023 · 13 investors · Hospitals and PhysiciansRule 506(b)
▶$3.1MraisedOct 2023 · 13 investors · Hospitals and Physicians
Rule 506(b)Officers, directors & promoters on the filing
- Pamela MontgomeryExecutive Officer
- Danniel StitesDirector
- Warren HosseinionnExecutive Officer, Director
- Elisa LuqmanExecutive Officer
- Thomas VoExecutive Officer, Director
- Mitchell CreemDirector
- Michael ReedDirector
- John WatersDirector
- Cheryl GrenasDirector
- Jon BatesExecutive Officer
- Offering amount
- $15M
- Amount sold
- $3.1M
- Minimum investment
- $50K
- Sales commissions
- $309K
- Placement agents
- Emerson Equity LLC
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4BraisedApr 2022 · 123 investors · Other Health CareRule 506(b)
▶$2.4BraisedApr 2022 · 123 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elisa LuqmanExecutive Officer
- Michael ChangExecutive Officer
- Denise PufalExecutive Officer
- Lawrence SchimmelExecutive Officer
- Cheryl GrenasDirector
- Thomas VoExecutive Officer, Director
- John WatersDirector
- Michael ReedDirector
- Mitchell CreemDirector
- Warren HosseinionExecutive Officer, Director
- Michael BowenExecutive Officer
- Pamela MontgomeryExecutive Officer
- Matthew YoungDirector
- Offering amount
- $2.4B
- Amount sold
- $2.4B
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.3MraisedDec 2021 · 73 investors · Other Health CareRule 506(b)
▶$11.3MraisedDec 2021 · 73 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jacob MargolinDirector
- Fred SternbergExecutive Officer, Director
- Mark FawcettDirector
- Brandon SimsDirector
- Michael BowenExecutive Officer
- Robert ChanDirector
- Mitchell CreemDirector
- David MeiriDirector
- Terrence BreslinDirector
- Elisa LuqmanExecutive Officer
- John WatersDirector
- Hosseinion WarrenExecutive Officer, Director
- Amount sold
- $11.3M
- Minimum investment
- $50K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$32MraisedMar 2021 · 58 investors · Other Health CareRule 506(b)
▶$32MraisedMar 2021 · 58 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Randall SternDirector
- David MeiriDirector
- Jacob MargolinDirector
- Mitchell Martin CreemDirector
- Richard ChanDirector
- Terrence Martin BreslinDirector
- John WatersDirector
- Lawrence SchimmelExecutive Officer
- Michael BowenExecutive Officer
- Elisa LuqmanExecutive Officer, Director
- Fred SternbergExecutive Officer, Director
- Warren HosseinionExecutive Officer, Director
- Andrew BarnettExecutive Officer
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedJan 2020 · 17 investors · Other Health CareRule 506(b)
▶$2.3MraisedJan 2020 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Elisa LuqmanExecutive Officer, Director
- Mark FawcettDirector
- Jacob MargolinExecutive Officer, Director
- John WatersDirector
- Warren HosseinionDirector
- Lawrence SchimmelExecutive Officer, Director
- Terence Martin BreslinDirector
- David MeiriDirector
- Mitchell CreemDirector
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- Minimum investment
- $25K
- Sales commissions
- $234.5K
- Placement agents
- Emerson Equity LLC
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.5MraisedNov 2019 · 114 investors · Other Health CareRule 506(b)
▶$24.5MraisedNov 2019 · 114 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mitchell CreemDirector
- Mark FawcettDirector
- Elisa LuqmanExecutive Officer, Director
- David MeiriDirector
- Terence Martin BreslinDirector
- Lawrence SchimmelExecutive Officer, Director
- Jacob MargolinExecutive Officer, Director
- John WatersDirector
- Warren HosseinionDirector
- Offering amount
- $24.5M
- Amount sold
- $24.5M
- Minimum investment
- $1
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedMay 2019 · 21 investors · Other Health CareRule 506(b)
▶$3.1MraisedMay 2019 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jacob MargolinExecutive Officer, Director
- Mihir ShahExecutive Officer
- Warren HosseinionDirector
- Lawrence SchimmelExecutive Officer, Director
- Martin BreslinDirector
- David MeiriDirector
- Charles KandzierskiExecutive Officer
- Offering amount
- $8.8M
- Amount sold
- $3.1M
- Minimum investment
- $10K
- Sales commissions
- $218.1K
- Placement agents
- Emerson Equity LLC
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$15.7MraisedApr 2019 · 31 investors · Other Health CareRule 506(b)
▶$15.7MraisedApr 2019 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin BreslinDirector
- David MeiriDirector
- Lawrence SchimmelDirector
- Warren HosseinionDirector
- Mihir ShahExecutive Officer
- Jacob MargolinExecutive Officer, Director
- Offering amount
- $15.7M
- Amount sold
- $15.7M
- Minimum investment
- $1
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Clinigence Holdings do?
- Nutex Health is a publicly traded healthcare management and operations company that owns, develops, and operates micro-hospitals, specialty hospitals, and hospital outpatient departments, as well as physician provider networks such as IPAs and MSOs. It serves communities and physician groups across the United States, operating over 27 facilities in 12 states with a focus on emergency and concierge-level care.
- Who founded Clinigence Holdings?
- Clinigence Holdings was founded by Jacob Margolin in 2018.
- How much funding has Clinigence Holdings raised?
- Clinigence Holdings has disclosed $2.5B raised across 8 rounds.
- Where is Clinigence Holdings headquartered?
- Clinigence Holdings is headquartered in Atlanta, US.